Evotec SE (EVOTF) FCF Margin (2021 - 2025)
Evotec SE's (EVOTF) quarterly FCF Margin came in at 32256.63% in Q4 2025, up 1263228.0% year-on-year from N/an in Q4 2024, and down 111550.8% quarter-over-quarter from 28.89% in Q3 2025.
Evotec SE (EVOTF) FCF Margin (2021 - 2025) Analysis & Trends
Evotec SE has disclosed FCF Margin across 5 years of filings, most recently posting 32256.63% for Q4 2025.
- FCF Margin for Q4 2025 came in at 32256.63%, up 1263228.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 10274.35% (down 197107.0% YoY), and the FY2025 annual result was 10.37%, up 1245268725.0% from the prior year.
- FCF Margin came in at 32256.63% for Q4 2025 at Evotec SE, down from 28.89% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4772.81% in Q4 2022 to a low of 44888.91% in Q4 2024.
- The 5-year median for FCF Margin is 0.03% (2021), against an average of 6730.51%.
- Across the five-year window, FCF Margin slumped 3529246 bps in 2023 and surged 1263228 bps in 2025, its largest moves.
- Evotec SE's FCF Margin stood at 1785.37% in 2021, then jumped by 167 bps to 4772.81% in 2022, then sank by 739 bps to 30519.65% in 2023, then plunged by 47 bps to 44888.91% in 2024, then climbed by 28 bps to 32256.63% in 2025.
- The last three FCF Margin figures came in at 32256.63% (Q4 2025), 28.89% (Q3 2025), and 44888.91% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | Evotec SE | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32,256.63% |
| Sep 30, 2025 | -28.89% |
| Dec 31, 2024 | -44,888.91% |
| Sep 30, 2024 | 37.52% |
| Dec 31, 2023 | -30,519.65% |
| Sep 30, 2023 | 34.64% |
| Jun 30, 2023 | 82.77% |
| Dec 31, 2022 | 4,772.81% |
| Sep 30, 2022 | -139.49% |
| Jun 30, 2022 | 125.11% |
| Mar 31, 2022 | 64.70% |
| Dec 31, 2021 | 1,785.37% |
| Sep 30, 2021 | -4.27% |
| Jun 30, 2021 | -22.80% |
| Mar 31, 2021 | 0.03% |